Back |
home / stock / nphc / nphc message board
Subject | By | Source | When |
---|---|---|---|
spss2215: Orphan Drug Status - Pediatric MS(RPI-78M) FDA TRIALS PHASE II Soon!!! | spss2215 | investorshangout | 01/16/2018 11:57:17 PM |
spss2215: RPI-78M Nutra Pharma's RPI-78M Granted Orphan Drug Status by the US Food and Drug Administ | spss2215 | investorshangout | 01/16/2018 11:55:42 PM |
spss2215: Endorsed and supported by Jack Brewer! Jack Brewer is the Executive Chairman & Portfolio M | spss2215 | investorshangout | 01/16/2018 11:52:44 PM |
spss2215: Nutra Pharma RPI-78M Granted Orphan Drug Status by the FDA September 8, 2015 https://fi | spss2215 | investorshangout | 01/16/2018 11:48:19 PM |
spss2215: Nutra Pharma Letter to Shareholders www.nutrapharma.com/Dec2017 shareholder letter.pdf | spss2215 | investorshangout | 01/16/2018 6:35:05 PM |
News, Short Squeeze, Breakout and More Instantly...
CORAL SPRINGS, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) earlier this week. On March 19, 2024, t...
Odyssey Marine Exploration Inc. (OMEX) is expected to report for quarter end 2023-06-30 The Very Good Food Company Inc. (VGFCQ) is expected to report for quarter end 2023-06-30 SeaChange International Inc. (SEAC) is expected to report for Q1 2024 Allena Pharmaceuticals Inc. (ALNAQ) is...
QualTek Services Inc. (QTEKQ) is expected to report for Q2 2023 Amerityre Corp (AMTY) is expected to report for quarter end 2023-06-30 BYD Co - Class H (BYDDF) is expected to report for quarter end 2023-06-30 Shionogi & Co. Ltd. ADR (SGIOY) is expected to report for Q1 2024 Ea...